Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Beyond the hype: 5 under-the-radar stocks common across India's 3 largest smallcap portfolios
India's top three smallcap mutual funds, managing over Rs 1.5 lakh crore, show strong consensus by holding five under-the-radar stocks across their portfolios. These include Kalpataru Projects International, KIMS, City Union Bank, PVR Inox, and Carborundum Universal, collectively representing 5.34% of their combined assets.

KIMS launches ₹1,500 crore QIP to repay debt and fund subsidiaries
KIMS has launched a ₹1,500 crore qualified institutions placement (QIP) through a 100% primary share issuance, with the indicative price set at ₹755 per share at up to a 3% discount to the last closing price. The hospital chain plans to use the proceeds to repay debt and fund investments in its subsidiaries, with the issue expected to be priced later this week and listed on the NSE and BSE thereafter.

Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 16 June 2026
Shares to buy or sell: Chandan Taparia has recommended three stocks to buy today, 16 June 2026 - Bharat Forge, BSE and The Phoenix Mills shares.

Why Bajaj Finserv AMC is bullish on banks, NBFCs and the Indian market
Nimesh Chandan, Chief Investment Officer at Bajaj Finserv AMC, said the recent correction has created opportunities in select gold financing companies. However, the fund house remains relatively cautious on jewellery stocks and is more constructive on gold financiers from a long-term perspective.

Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 12 June 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 12 June 2026Mint
Ambani-backed robot startup seeks $100 million to take on China
Reliance-backed robotics startup Addverb Technologies is looking to raise over $100 million to fund expansion into humanoid robots, AI and advanced automation. The company, which generates half its revenue overseas, targets a spot among the world's top 10 robotics firms within five years.

Glenmark Pharma Profit Expected To Soar 5x in Two Years, Says Motilal Oswal — Check Target Price
Glenmark Pharma's shares are likely to remain in focus after Motilal Oswal has reiterated its positive stance on the stock.

ICICI Lombard: AI Integration Lifts Growth Outlook — Buy, Sell or Hold? Read Motilal Oswal's Analysis
Leadership in motor insurance, accelerating momentum in retail health, expanding distribution capabilities, growing AI integration and a strong balance sheet remains ICICI Lombard's key growth drivers.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.